All Stories

  1. Incidence, survival and mortality trends of bladder cancer in Sweden 1997–2016

    Article • Scandinavian Journal of Urology, July 2019, Taylor & Francis

    Amir Sherif, Staffan Jahnson

  2. Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival

    Article • Scandinavian Journal of Urology, June 2019, Taylor & Francis

    Amir Sherif

  3. Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe)

    Article • Scandinavian Journal of Urology, May 2019, Taylor & Francis

    Amir Sherif, Staffan Jahnson

  4. Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer

    Article • August 2018, Wiley

    Amir Sherif

  5. Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients

    Article • Clinical Epigenetics, August 2018, Springer Science + Business Media

    Amir Sherif

  6. Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway

    Article • PLoS ONE, July 2018, PLOS

    Amir Sherif

  7. Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer

    Article • July 2018, Elsevier

    Amir Sherif

  8. The long perspective in emergence of neoadjuvant chemotherapy for bladder cancer in Ontario, Canada—space for improvement with regular and organized multidisciplinary team meetings

    Article • Translational Andrology and Urology, June 2018, AME Publishing Company

    Amir Sherif

  9. Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer

    Article • Scandinavian Journal of Urology, April 2018, Taylor & Francis

    Amir Sherif

  10. Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness

    Article • Cancer Immunology Research, March 2018, American Association for Cancer Research (AACR)

    Amir Sherif

  11. Improved outcome over time in TaG1G2 tumors

    Article • European Urology Supplements, March 2018, Elsevier

    Amir Sherif

  12. Short term reoperation rate after cystectomy and urinary diversion within a national population based registry

    Article • European Urology Supplements, March 2018, Elsevier

    Amir Sherif

  13. Increasing incidence and more active therapy of patients with bladder cancer in Sweden: A population based registry study

    Article • European Urology Supplements, March 2018, Elsevier

    Amir Sherif

  14. Is there finally an increasing survival of patients with urinary bladder cancer? A nationwide study in Sweden 1997–2016

    Article • European Urology Supplements, March 2018, Elsevier

    Amir Sherif

  15. Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer

    Article • Bladder Cancer, January 2018, IOS Press

    Amir Sherif

  16. Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology

    Article • European Urology, October 2017, Elsevier

    Amir Sherif

  17. Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)

    Article • BMJ Open, September 2017, BMJ

    Amir Sherif

  18. Evaluation of the diagnostic accuracy of UBC® Rapid in bladder cancer: a Swedish multicentre study

    Article • Scandinavian Journal of Urology, April 2017, Taylor & Francis

    Amir Sherif

  19. Intravesical instillations and cancer-specific survival in patients with primary carcinoma in situ of the urinary bladder

    Article • Scandinavian Journal of Urology, March 2017, Taylor & Francis

    Amir Sherif

  20. Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer

    Article • Clinical Immunology, March 2017, Elsevier

    Amir Sherif

  21. Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report

    Article • World Journal of Urology, October 2016, Springer Science + Business Media

    Amir Sherif

  22. Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours

    Article • British Journal of Cancer, September 2016, Springer Science + Business Media

    Amir Sherif

  23. A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy

    Article • SpringerPlus, July 2016, Springer Science + Business Media

    Amir Sherif

  24. 621 Increased use of neoadjuvant chemotherapy for muscle invasive bladder cancer does not affect the rate of postoperative complications – results from the Swedish cystectomy registry

    Article • European Urology Supplements, March 2016, Elsevier

    Amir Sherif

  25. Pilot study of adoptive immunotherapy with sentinel node-derived T cells in muscle-invasive urinary bladder cancer

    Article • Scandinavian Journal of Urology, July 2015, Taylor & Francis

    Amir Sherif

  26. B cells in tumor draining lymph nodes act as efficient antigen presenting cells in cancer patients

    Article • Journal for ImmunoTherapy of Cancer, January 2015, Springer Science + Business Media

    Amir Sherif

  27. Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma

    Article • Urologic Oncology Seminars and Original Investigations, November 2014, Elsevier

    Amir Sherif

  28. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

    Article • European Urology, April 2014, Elsevier

    Amir Sherif

  29. 116 Chemoinduced downstaging as a potential surrogate marker of efficacy and of increased survival following neoadjuvant chemotherapy of locally advanced urothelial urinary bladder cancer

    Article • European Urology Supplements, April 2014, Elsevier

    Amir Sherif

  30. The effects of a physical exercise programme after radical cystectomy for urinary bladder cancer. A pilot randomized controlled trial

    Article • Clinical Rehabilitation, November 2013, SAGE Publications

    Amir Sherif

  31. EAU Guidelines on Primary Urethral Carcinoma

    Article • European Urology, November 2013, Elsevier

    Amir Sherif

  32. Response to Comment on "Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies"

    Article • The Journal of Immunology, October 2013, The American Association of Immunologists

    Amir Sherif

  33. The many flavors of tumor-associated B cells

    Article • OncoImmunology, August 2013, Taylor & Francis

    Amir Sherif

  34. Multiplex B Cell Characterization in Blood, Lymph Nodes, and Tumors from Patients with Malignancies

    Article • The Journal of Immunology, April 2013, The American Association of Immunologists

    Amir Sherif

  35. The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation

    Article • Clinical & Experimental Immunology, April 2013, Wiley

    Amir Sherif

  36. Clinical activity of sorafenib in a previously treated advanced urothelial cancer patient

    Article • Anti-Cancer Drugs, March 2013, Wolters Kluwer Health

    Amir Sherif

  37. The effect of chemotherapeutic drugs on human B lymphocytes

    Article • Journal for ImmunoTherapy of Cancer, January 2013, Springer Science + Business Media

    Amir Sherif

  38. Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer

    Article • European Urology, June 2012, Elsevier

    Amir Sherif

  39. 927 Sentinel node detection in renal cell carcinoma. A feasibility study

    Article • European Urology Supplements, February 2012, Elsevier

    Professor Katrine Riklund, Amir Sherif

  40. Sentinel node detection in renal cell carcinoma. A feasibility study for detection of tumour-draining lymph nodes

    Article • BJU International, August 2011, Wiley

    Professor Katrine Riklund, Amir Sherif

  41. Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines

    Article • European Urology, June 2011, Elsevier

    Amir Sherif

  42. 651 CT-EVALUATION OF THE FIRST EIGHTEEN PATIENTS WITH ADVANCED UROTHELIAL URINARY BLADDER CANCER SCHEDULED TO UNDERGO T-CELL BASED ADOPTIVE IMMUNOTHERAPY

    Article • European Urology Supplements, March 2011, Elsevier

    Amir Sherif

  43. FOXP3 and survival in urinary bladder cancer

    Article • BJU International, January 2011, Wiley

    Amir Sherif

  44. New Advances of Sentinel Node Detection in Penile Carcinoma with Clinical Implications and a Perspective on Possible Further Research

    Article • European Urology, November 2010, Elsevier

    Amir Sherif

  45. Neoadjuvant Chemotherapy

    Article • October 2010, Springer Science + Business Media

    Amir Sherif

  46. Feasibility of T-Cell-Based Adoptive Immunotherapy in the First 12 Patients with Advanced Urothelial Urinary Bladder Cancer. Preliminary Data on a New Immunologic Treatment Based on the Sentinel Node Concept

    Article • European Urology, July 2010, Elsevier

    Amir Sherif

  47. Editorial Comment on: FDG-PET/CT for the Preoperative Lymph Node Staging of Invasive Bladder Cancer

    Article • European Urology, April 2010, Elsevier

    Amir Sherif

  48. The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer

    Article • European Urology, April 2009, Elsevier

    Amir Sherif

  49. Detection of Immune Responses in Sentinel Nodes Draining Human Urinary Bladder Cancer

    Article • Scandinavian Journal of Immunology, June 2008, Wiley

    Amir Sherif

  50. DETECTION OF IMMUNE RESPONSES AGAINST URINARY BLADDER CANCER IN SENTINEL LYMPH NODES

    Article • European Urology Supplements, March 2008, Elsevier

    Amir Sherif

  51. POS-02.21: Upstaging in T1G3 urothelial urinary bladder cancer – an evaluation of data from Nordic cystectomy trial 1

    Article • Urology, September 2007, Elsevier

    Amir Sherif

  52. Treatment of muscle-invasive bladder cancer

    Article • Expert Review of Anticancer Therapy, September 2007, Taylor & Francis

    Amir Sherif

  53. MP-13.07

    Article • Urology, November 2006, Elsevier

    Amir Sherif

  54. PD-11.04

    Article • Urology, November 2006, Elsevier

    Amir Sherif

  55. MP-15.04

    Article • Urology, November 2006, Elsevier

    Amir Sherif

  56. MP-13.08

    Article • Urology, November 2006, Elsevier

    Amir Sherif

  57. Hybrid SPECT-CT: An Additional Technique for Sentinel Node Detection of Patients with Invasive Bladder Cancer

    Article • European Urology, July 2006, Elsevier

    Amir Sherif

  58. Detection of Immune Responses Against Urinary Bladder Cancer in Sentinel Lymph Nodes

    Article • European Urology, January 2006, Elsevier

    Amir Sherif

  59. Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data

    Article • European Urology, August 2005, Elsevier

    Amir Sherif

  60. Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data

    Article • European Urology, August 2005, Elsevier

    Amir Sherif

  61. RE: EXTENDED RADICAL LYMPHADENECTOMY IN PATIENTS WITH UROTHELIAL BLADDER CANCER: RESULTS OF A PROSPECTIVE MULTICENTER STUDY

    Article • The Journal of Urology, July 2004, Elsevier

    Amir Sherif

  62. 315: CT-Enhanced Lymphoscintigraphy in Detecting Sentinel Lymph Nodes of Invasive Bladder Cancer

    Article • The Journal of Urology, April 2004, Elsevier

    Amir Sherif

  63. 327: Downstaging Analysis Following Neoadjuvant Cisplatinum Based Combination Chemotherapy for Invasive Bladder Carcinoma.Evaluation of Two Combined Prospective Nordic Trials

    Article • The Journal of Urology, April 2004, Elsevier

    Amir Sherif

  64. Neoadjuvant Cisplatinum Based Combination Chemotherapy in Patients with Invasive Bladder Cancer: A Combined Analysis of Two Nordic Studies

    Article • European Urology, March 2004, Elsevier

    Amir Sherif

  65. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

    Article • The Lancet, June 2003, Elsevier

    Amir Sherif

  66. Early Metastatic Progression of Bladder Carcinoma: Molecular Profile of Primary Tumor and Sentinel Lymph Node

    Article • The Journal of Urology, November 2002, Elsevier

    Amir Sherif

  67. Early Metastatic Progression of Bladder Carcinoma: Molecular Profile of Primary Tumor and Sentinel Lymph Node

    Article • The Journal of Urology, November 2002, Elsevier

    Amir Sherif

  68. Neoadjuvant Cisplatin-Methotrexate Chemotherapy for Invasive Bladder Cancer - Nordic Cystectomy Trial 2

    Article • Scandinavian Journal of Urology and Nephrology, January 2002, Taylor & Francis

    Amir Sherif

  69. Endovascular Approach to Treating Secondary Arterioureteral Fistula

    Article • Scandinavian Journal of Urology and Nephrology, January 2002, Taylor & Francis

    Amir Sherif

  70. Sentinel node detection in advanced bladder cancer. First report of a prospective multicenter study

    Article • European Urology Supplements, January 2002, Elsevier

    Amir Sherif

  71. LYMPHATIC MAPPING AND DETECTION OF SENTINEL NODES IN PATIENTS WITH BLADDER CANCER

    Article • The Journal of Urology, September 2001, Elsevier

    Amir Sherif

  72. Arterio-ureteral Fistula – a Systematic Review

    Article • European Journal of Vascular and Endovascular Surgery, September 2001, Elsevier

    Amir Sherif

  73. Lymphatic mapping and detection of sentinel node in patients with urinary bladder cancer

    Article • European Journal of Cancer, April 2001, Elsevier

    Amir Sherif